Norris Perne & French LLP Danaher Corp Transaction History

Norris Perne & French LLP

$1.3 Billion
Q4 2024

A detailed history of Norris Perne & French LLP transactions in Danaher Corp stock. As of the latest transaction made, Norris Perne & French LLP holds 130,356 shares of DHR stock, worth $32 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares

130,356

Previous 82,095 58.79%

Holding current value

$32 Million

Previous $22.8 Million 31.12%

% of portfolio

2.3%

Previous 1.68%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$226.16 - $274.52 $10.9 Million - $13.2 Million	48,261 Added 58.79%	130,356 $29.9 Million
Q3 2024 Oct 28, 2024	BUY	$239.25 - $280.76 $241,403 - $283,286	1,009 Added 1.24%	82,095 $22.8 Million
Q2 2024 Jul 24, 2024	BUY	$235.51 - $267.98 $544,970 - $620,105	2,314 Added 2.94%	81,086 $20.3 Million
Q1 2024 Apr 16, 2024	BUY	$224.58 - $256.19 $365,167 - $416,564	1,626 Added 2.11%	78,772 $19.7 Million
Q4 2023 Jan 22, 2024	BUY	$185.1 - $233.13 $250,070 - $314,958	1,351 Added 1.78%	77,146 $17.8 Million
Q3 2023 Oct 18, 2023	BUY	$233.08 - $265.59 $233,779 - $266,386	1,003 Added 1.34%	75,795 $18.8 Million
Q2 2023 Jul 19, 2023	BUY	$224.99 - $256.14 $608,372 - $692,602	2,704 Added 3.75%	74,792 $18 Million
Q1 2023 Apr 20, 2023	BUY	$239.75 - $277.0 $663,148 - $766,182	2,766 Added 3.99%	72,088 $18.2 Million
Q4 2022 Jan 24, 2023	BUY	$241.42 - $282.29 $81,358 - $95,131	337 Added 0.49%	69,322 $0
Q3 2022 Oct 13, 2022	BUY	$247.06 - $1507.4 $158,365 - $966,243	641 Added 0.94%	68,985 $17.8 Million
Q2 2022 Aug 11, 2022	BUY	$237.11 - $299.66 $384,355 - $485,748	1,621 Added 2.43%	68,344 $17.3 Million
Q1 2022 Apr 26, 2022	BUY	$257.27 - $315.76 $35,760 - $43,890	139 Added 0.21%	66,723 $19.6 Million
Q4 2021 Jan 26, 2022	SELL	$292.08 - $329.01 $36,802 - $41,455	-126 Reduced 0.19%	66,584 $21.9 Million
Q3 2021 Oct 26, 2021	BUY	$272.21 - $332.43 $85,201 - $104,050	313 Added 0.47%	66,710 $20.3 Million
Q2 2021 Jul 20, 2021	BUY	$225.08 - $271.69 $205,272 - $247,781	912 Added 1.39%	66,397 $17.8 Million
Q1 2021 Apr 30, 2021	BUY	$212.38 - $245.9 $293,084 - $339,342	1,380 Added 2.15%	65,485 $14.7 Million
Q4 2020 Jan 27, 2021	SELL	$212.5 - $245.46 $1.9 Million - $2.19 Million	-8,939 Reduced 12.24%	64,105 $14.2 Million
Q3 2020 Oct 26, 2020	SELL	$177.16 - $215.33 $29,408 - $35,744	-166 Reduced 0.23%	73,044 $15.7 Million
Q2 2020 Jul 23, 2020	SELL	$128.7 - $176.83 $1.41 Million - $1.93 Million	-10,928 Reduced 12.99%	73,210 $12.9 Million
Q1 2020 Apr 16, 2020	SELL	$121.39 - $169.05 $803,601 - $1.12 Million	-6,620 Reduced 7.29%	84,138 $11.6 Million
Q4 2019 Jan 22, 2020	BUY	$133.47 - $153.48 $1.33 Million - $1.53 Million	9,940 Added 12.3%	90,758 $13.9 Million
Q3 2019 Oct 24, 2019	BUY	$135.4 - $146.47 $36,828 - $39,839	272 Added 0.34%	80,818 $11.7 Million
Q2 2019 Jul 19, 2019	SELL	$124.88 - $143.73 $138,616 - $159,540	-1,110 Reduced 1.36%	80,546 $11.5 Million
Q1 2019 Apr 29, 2019	SELL	$97.62 - $132.29 $3.26 Million - $4.42 Million	-33,415 Reduced 29.04%	81,656 $10.8 Million
Q4 2018 Jan 28, 2019	BUY	$94.85 - $109.54 $133,359 - $154,013	1,406 Added 1.24%	115,071 $11.9 Million
Q3 2018 Oct 29, 2018	BUY	$98.13 - $108.9 $420,683 - $466,854	4,287 Added 3.92%	113,665 $12.4 Million
Q2 2018 Jul 24, 2018	BUY	$96.1 - $103.24 $251,397 - $270,075	2,616 Added 2.45%	109,378 $10.8 Million
Q1 2018 Apr 17, 2018	SELL	$92.16 - $103.8 $7,741 - $8,719	-84 Reduced 0.08%	106,762 $10.5 Million
Q4 2017 Jan 23, 2018	BUY	$85.26 - $94.62 $132,579 - $147,134	1,555 Added 1.48%	106,846 $9.92 Million
Q3 2017 Nov 01, 2017	BUY	$79.29 - $88.45 $8.35 Million - $9.31 Million	105,291	105,291 $9.03 Million

Others Institutions Holding DHR

# of Institutions

2,483

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.54M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $179B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account

Norris Perne & French LLP Danaher Corp Transaction History